Glyoxalase-I, Human, clone 17E6A12/G4
Monoclonal antibody 17E6A12/G4 recognizes human glyoxalase-I (GLO1). GLO1 is a major protein form the glyoxalase systems which is present in the cytosol of all cells. The function of this system is the metabolism of reactive dicarbonyl metabolites to less reactive products. GLO1 catalysis the isomerization of hemithioacetal derived from methylglyoxal and glutathione. GLO1 prevents the harmful accumulation of methylglyoxal. The GLO1 gene exist of 3 phenotypes. Embodying the homozygous and heterozygous expression of the protein. GLO1 consists of alpha helical regions and multiple beta strands. Protein and DNA modification by substrates of the glyoxalase system is linked to healthy aging, including diseases like diabetes and vascular dysfunction. This vascular impairment could lead to complications like retinopathy, nephropathy and bad wound healing. Overexpression of GLO1 in endothelial cells under hyperglycemic condition can revert the negative effects on angiogenesis. Glo1 is also considered to be a tumor suppressor protein and it is ubiquitously expressed in most tumor cells. Therefor inducers of GLO1 expression could be useful in cancer treatment.
Calculate your ELISA data easily
With the ELISA calculator you can easily calculate ELISA data. Assayfit Pro helps to perform curve fitting. The calculator generates advanced reports, fit graph, fit parameters and goodness of fit are shown.
Latest Hycult Biotech news
- Discover Cross-Reactive Complement ELISA for NHP ResearchBridging Human and NHP Complement Research. At Hycult Biotech, we understand the importance of testing therapeutic agents on non-human primates (NHP) samples in order to get approval to enter clinical phases. That is why we have committed to the following initiative: Testing our existing complement ELISA assays for NHP research. Why Non Human Primate Samples… Read more: Discover Cross-Reactive Complement ELISA for NHP Research
- New Human Complement Pathway AssaysWe are very proud of our newly developed human classical and alternative complement pathway assays. They are produced in response to a growing demand for quantitative investigation of complement inhibitors or regulators at lower sample dilutions. This development aims to address the issue of false negative results, enabling more accurate and reliable analysis of complement… Read more: New Human Complement Pathway Assays
- Navigating the pitfalls in complement analysisOur colleague Erik Toonen shared his experience on how to analyze complement at the Complement-based Drug Development Summit in Boston in September 11-13th, 2023. He showed valuable insights on analyzing complements. For accurate complement analysis, it is important that not only the correct technique is used but also that pre-analytical sample handling is performed in… Read more: Navigating the pitfalls in complement analysis